Akebia Therapeutics Accounts Receivable (Quarterly) Insights

Akebia Therapeutics Inc (AKBA)

1.13 +0.05 (+4.63%) USD | NASDAQ | May 31, 16:00

1.12 -0.01 (-0.88%) After-Hours: 20:00

Accounts Receivable (Quarterly) Chart

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	26.62M
December 31, 2023	39.29M
September 30, 2023	22.59M
June 30, 2023	19.57M
March 31, 2023	17.78M
December 31, 2022	40.28M
September 30, 2022	23.09M
June 30, 2022	81.87M
March 31, 2022	64.58M
December 31, 2021	51.58M
September 30, 2021	49.69M
June 30, 2021	35.00M
March 31, 2021	35.23M
December 31, 2020	26.85M
September 30, 2020	24.47M
June 30, 2020	39.12M
March 31, 2020	104.87M
December 31, 2019	38.86M
September 30, 2019	29.65M
June 30, 2019	28.89M
March 31, 2019	48.44M

Date	Value
December 31, 2018	16.67M
September 30, 2018	0.688M
June 30, 2018	0.132M
March 31, 2018	35.85M
December 31, 2017	34.22M
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016	33.82M
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015	0.014M
June 30, 2015	0.048M
March 31, 2015	0.074M
December 31, 2014
September 30, 2014	0.057M
June 30, 2014	0.114M
March 31, 2014	0.1194M
December 31, 2013	0.135M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

17.78M

Minimum

Mar 2023

104.87M

Maximum

Mar 2020

40.00M

Average

35.12M

Median

Accounts Receivable (Quarterly) Benchmarks